ANRO CIK: 1999480

Alto Neuroscience, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY23
FY24
FY25
FY23 – FY25

Assets

(positive)
Change from FY23 to FY25
millions USD
FY23:
85.4
FY24:
169
FY25:
178
(positive)
Change from FY23 to FY25
millions USD
FY23:
1.24
FY24:
8.21
FY25:
6.97
Total assets
Change from FY23 to FY25
millions USD
FY23:
86.6
FY24:
178
FY25:
185

Liabilities & Equity

(negative)
Change from FY23 to FY25
millions USD
FY23:
5.61
FY24:
10.0
FY25:
11.3
(negative)
Change from FY23 to FY25
millions USD
FY23:
11.2
FY24:
16.1
FY25:
22.2
(positive)
Change from FY23 to FY25
millions USD
FY23:
−71.7
FY24:
151
FY25:
151
Total liabilities & equity
Change from FY24 to FY25
millions USD
FY23:
–
FY24:
178
FY25:
185

All amounts in millions USD Data source:SEC EDGAR